This company listing is no longer active
4D pharma Balance Sheet Health
Financial Health criteria checks 3/6
Key information
36.5%
Debt to equity ratio
US$11.84m
Debt
| Interest coverage ratio | n/a |
| Cash | US$20.97m |
| Equity | US$32.42m |
| Total liabilities | US$26.38m |
| Total assets | US$58.79m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: DDDD's short term assets ($34.5M) exceed its short term liabilities ($6.6M).
Long Term Liabilities: DDDD's short term assets ($34.5M) exceed its long term liabilities ($19.8M).
Debt to Equity History and Analysis
Debt Level: DDDD has more cash than its total debt.
Reducing Debt: DDDD's debt to equity ratio has increased from 0% to 36.5% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if DDDD has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if DDDD has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.